Laura G. Corral

7.1k total citations · 3 hit papers
61 papers, 6.0k citations indexed

About

Laura G. Corral is a scholar working on Hematology, Molecular Biology and Immunology. According to data from OpenAlex, Laura G. Corral has authored 61 papers receiving a total of 6.0k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Hematology, 29 papers in Molecular Biology and 15 papers in Immunology. Recurrent topics in Laura G. Corral's work include Multiple Myeloma Research and Treatments (25 papers), Immune Cell Function and Interaction (9 papers) and Chronic Lymphocytic Leukemia Research (8 papers). Laura G. Corral is often cited by papers focused on Multiple Myeloma Research and Treatments (25 papers), Immune Cell Function and Interaction (9 papers) and Chronic Lymphocytic Leukemia Research (8 papers). Laura G. Corral collaborates with scholars based in United States, Switzerland and Cuba. Laura G. Corral's co-authors include Gilla Kaplan, George W. Muller, Patrick Haslett, David Stirling, Christopher Ocampo, Roger Chen, Matthew L. Albert, David H. Raulet, Yuxi Chen and Lai Mun Wong and has published in prestigious journals such as Cell, Circulation and Journal of Clinical Investigation.

In The Last Decade

Laura G. Corral

59 papers receiving 5.8k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Differential cytokine modulation and T cell activation by two distinct classes of thalidomide analogues that are potent inhibitors of TNF-alpha.

1999 635 citations Laura G. Corral, Patrick Haslett et al. profile →
Differential Cytokine Modulation and T Cell Activation by Two Distinct Classes of Thalidomide Analogues That Are Potent Inhibitors of TNF-α

1999 577 citations Laura G. Corral, Patrick Haslett et al. The Journal of Immunology profile →
Structure of the human Cereblon–DDB1–lenalidomide complex reveals basis for responsiveness to thalidomide analogs

2014 371 citations Antonia Lopez‐Girona, Laura G. Corral et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Laura G. Corral United States	36	2.9k	2.8k	1.8k	1.4k	856	61	6.0k
Martin Sattler United States	55	4.3k 1.5×	3.1k 1.1×	2.4k 1.3×	1.2k 0.8×	1.5k 1.8×	151	8.6k
Nicholas J. Donato United States	38	3.3k 1.1×	2.5k 0.9×	2.0k 1.1×	607 0.4×	1.8k 2.1×	111	6.7k
Jürgen Mestan Switzerland	31	2.3k 0.8×	1.8k 0.7×	1.1k 0.6×	509 0.4×	1.4k 1.7×	56	5.1k
Patrick Mayeux France	52	4.1k 1.4×	3.0k 1.1×	2.0k 1.1×	1.8k 1.2×	1.3k 1.5×	151	7.9k
P. Maslak United States	32	2.8k 1.0×	1.7k 0.6×	3.1k 1.7×	1.1k 0.8×	683 0.8×	116	6.3k
Christoph Driessen Switzerland	45	2.9k 1.0×	1.4k 0.5×	1.7k 0.9×	1.5k 1.0×	328 0.4×	144	5.8k
Øystein Bruserud Norway	45	3.9k 1.4×	3.9k 1.4×	1.7k 1.0×	1.9k 1.3×	1.1k 1.3×	350	8.2k
Daniel Kirchhofer United States	47	2.4k 0.8×	2.1k 0.8×	660 0.4×	1.1k 0.7×	828 1.0×	116	6.4k
Didier Bouscary France	40	3.5k 1.2×	2.3k 0.8×	1.4k 0.8×	993 0.7×	1.1k 1.2×	163	6.3k
Mark Heaney United States	31	2.1k 0.7×	1.0k 0.4×	962 0.5×	695 0.5×	906 1.1×	91	4.5k

Countries citing papers authored by Laura G. Corral

Since Specialization

Citations

This map shows the geographic impact of Laura G. Corral's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura G. Corral with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura G. Corral more than expected).

Fields of papers citing papers by Laura G. Corral

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura G. Corral. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura G. Corral. The network helps show where Laura G. Corral may publish in the future.

Co-authorship network of co-authors of Laura G. Corral

This figure shows the co-authorship network connecting the top 25 collaborators of Laura G. Corral. A scholar is included among the top collaborators of Laura G. Corral based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura G. Corral. Laura G. Corral is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Meiler, Steffen E., Marlene Wade, F. Kutlar, et al.. (2011). Pomalidomide augments fetal hemoglobin production without the myelosuppressive effects of hydroxyurea in transgenic sickle cell mice. Blood. 118(4). 1109–1112. 61 indexed citations

Gaidarova, Svetlana, Laura G. Corral, Emilia Glezer, Peter Schäfer, & Antonia Lopez‐Girona. (2009). Treatment of MCL Cells with Combined Rituximab and Lenalidomide Enhances NK-Mediated Synapse Formation and Cell Killing.. Blood. 114(22). 1687–1687. 6 indexed citations

Gaidarova, Svetlana, Jianwu Li, Laura G. Corral, et al.. (2009). Lenalidomide Alone and in Combination with Rituximab Enhances NK Cell Immune Synapse Formation in Chronic Lymphocytic Leukemia (CLL) Cells in Vitro through Activation of Rho and Rac1 GTPases.. Blood. 114(22). 3441–3441. 9 indexed citations

Zhu, Dan, et al.. (2008). Immunomodulatory drugs Revlimid® (lenalidomide) and CC-4047 induce apoptosis of both hematological and solid tumor cells through NK cell activation. Cancer Immunology Immunotherapy. 57(12). 1849–1859. 138 indexed citations

Parseval, Laure A Moutouh-de, Dominique Verhelle, Emilia Glezer, et al.. (2008). Pomalidomide and lenalidomide regulate erythropoiesis and fetal hemoglobin production in human CD34+ cells. Journal of Clinical Investigation. 118(1). 248–258. 141 indexed citations

Sablina, Anna, Wen Chen, Jason D. Arroyo, et al.. (2007). The Tumor Suppressor PP2A Aβ Regulates the RalA GTPase. Cell. 129(5). 969–982. 166 indexed citations

Zhu, Dan, et al.. (2005). IMiDs enhance tumor cell apoptosis in tumor/PBMC co-cultures. Cancer Research. 65. 190–191. 2 indexed citations

Brady, Helen, Dominique Verhelle, Laura G. Corral, et al.. (2005). Lenalidomide and Novel Immunomodulatory Drugs (IMiDs®): A New Approach to the Regulation of Erythropoiesis and Hemoglobin Synthesis in Anemia.. Blood. 106(11). 2702–2702. 3 indexed citations

Tringler, Barbara, Wenhui Liu, Laura G. Corral, et al.. (2005). B7-H4 overexpression in ovarian tumors. Gynecologic Oncology. 100(1). 44–52. 124 indexed citations

10.

Man, Hon‐Wah, Laura G. Corral, David Stirling, & George W. Muller. (2003). α-Fluoro-substituted thalidomide analogues. Bioorganic & Medicinal Chemistry Letters. 13(20). 3415–3417. 38 indexed citations

11.

Schäfer, Peter, Anita K. Gandhi, Roger S. Chen, et al.. (2003). Enhancement of Cytokine Production and AP-1 Transcriptional Activity in T Cells by Thalidomide-Related Immunomodulatory Drugs. Journal of Pharmacology and Experimental Therapeutics. 305(3). 1222–1232. 155 indexed citations

12.

Corral, Laura G., Thomas Hanke, Russell E. Vance, Dragana Cado, & David H. Raulet. (2000). NK cell expression of the killer cell lectin-like receptor G1 (KLRG1), the mouse homolog of MAFA, is modulated by MHC class I molecules. European Journal of Immunology. 30(3). 920–930. 76 indexed citations

13.

Oliver, Stephen J., Sherry Freeman, Laura G. Corral, Christopher Ocampo, & Gilla Kaplan. (1999). Thalidomide analogue CC1069 inhibits development of rat adjuvant arthritis. Clinical & Experimental Immunology. 118(2). 315–321. 26 indexed citations

14.

Muller, George W., Roger Chen, Laura G. Corral, et al.. (1999). Amino-substituted thalidomide analogs: Potent inhibitors of TNF-α production. Bioorganic & Medicinal Chemistry Letters. 9(11). 1625–1630. 290 indexed citations

15.

Corral, Laura G., Patrick Haslett, George W. Muller, et al.. (1999). Differential Cytokine Modulation and T Cell Activation by Two Distinct Classes of Thalidomide Analogues That Are Potent Inhibitors of TNF-α. The Journal of Immunology. 163(1). 380–386. 577 indexed citations breakdown →

16.

Muller, George W., et al.. (1998). Thalidomide analogs and PDE4 inhibition. Bioorganic & Medicinal Chemistry Letters. 8(19). 2669–2674. 61 indexed citations

17.

Raulet, David H., Werner Held, Isabel Corrêa, et al.. (1997). Specificity, tolerance and developmental regulation of natural killer cells defined by expression of class I‐specific Ly49 receptors. Immunological Reviews. 155(1). 41–52. 189 indexed citations

18.

Raulet, David H., Isabel Corrêa, Laura G. Corral, Jeffrey R. Dorfman, & Ming‐Fan Wu. (1995). Inhibitory effects of class I molecules on murine NK cells: speculations on function, specificity and self-tolerance. Seminars in Immunology. 7(2). 103–107. 21 indexed citations

19.

Hernández, P, et al.. (1993). p 53 gene rearrangements in chronic myelocytic leukemia. Annals of Hematology. 66(2). 81–83. 8 indexed citations

20.

Corral, Laura G., Laurie Post, & Thomas J. Montville. (1988). Antimicrobial Activity of Sodium Bicarbonate. Journal of Food Science. 53(3). 981–982. 86 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact